Beacon Pointe Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.41M | Sell |
|
|||||
|
2025
Q2 | $2.88M | Sell |
|
|||||
|
2025
Q1 | $8.9M | Buy |
|
|||||
|
2024
Q4 | $3.26M | Sell |
|
|||||
|
2024
Q3 | $5.4M | Sell |
|
|||||
|
2024
Q2 | $7.02M | Sell |
|
|||||
|
2024
Q1 | $6.72M | Buy |
|
|||||
|
2023
Q4 | $5.29M | Sell |
|
|||||
|
2023
Q3 | $10.8M | Buy |
|
|||||
|
2023
Q2 | $1.76M | Sell |
|
|||||
|
2023
Q1 | $1.81M | Sell |
|
|||||
|
2022
Q4 | $1.57M | Buy |
|
|||||
|
2022
Q3 | $883K | Sell |
|
|||||
|
2022
Q2 | $999K | Sell |
|
|||||
|
2022
Q1 | $5.66M | Buy |
|
|||||
|
2021
Q4 | $1.41M | Buy |
|
|||||
|
2021
Q3 | $690K | Sell |
|
|||||
|
2021
Q2 | $960K | Buy |
|
|||||
|
2021
Q1 | $384K | Buy |
|
|||||
|
2020
Q4 | $219K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $3.98M | Buy |
|